Satisfaction of switching to combination therapy with lixisenatide and basal insulin in patients with type 2 diabetes receiving multiple daily insulin injection therapy: A randomized controlled trial

Lignende værker

• Switching to Once-Daily Insulin Degludec/Insulin Aspart from Basal Insulin Improves Postprandial Glycemia in Patients with Type 2 Diabetes Mellitus: Randomized Controlled Trial
  af: Cho, Kyu Yong, et al.
  Udgivet: (2020)
• Lixisenatide as add-on therapy to basal insulin
  af: Brown, Dominique Xavier, et al.
  Udgivet: (2013)
• Beneficial effects of switching to denosumab from bisphosphonates or selective estrogen receptor modulators in postmenopausal women with type 2 diabetes and osteopenia/osteoporosis
  af: Miyoshi, Arina, et al.
  Udgivet: (2020)
• Impaired insulin secretion predicting unstable glycemic variability and time below range in type 2 diabetes patients regardless of glycated hemoglobin or diabetes treatment
  af: Miya, Aika, et al.
  Udgivet: (2020)
• Log-linear relationship between endogenous insulin secretion and glycemic variability in patients with type 2 diabetes on continuous glucose monitoring
  af: Miya, Aika, et al.
  Udgivet: (2021)